Clinical Trial Update: A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

View source ↗

Summary

Provides an update on a clinical study evaluating ribociclib in combination with hormonal therapy for HR+/HER2- advanced or metastatic breast cancer; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Status: RECRUITING